Legal & General Group Plc Buys New Position in Heartflow, Inc. $HTFL

Legal & General Group Plc purchased a new position in Heartflow, Inc. (NASDAQ:HTFL - Free Report) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 34,020 shares of the company's stock, valued at approximately $998,000.

Other institutional investors and hedge funds have also modified their holdings of the company. Caitong International Asset Management Co. Ltd bought a new stake in Heartflow during the fourth quarter valued at about $27,000. Russell Investments Group Ltd. bought a new position in shares of Heartflow in the fourth quarter worth about $45,000. Essential Partners LLC purchased a new position in shares of Heartflow during the 1st quarter valued at about $57,000. Strs Ohio purchased a new position in shares of Heartflow during the 4th quarter valued at about $99,000. Finally, Police & Firemen s Retirement System of New Jersey purchased a new stake in Heartflow in the 4th quarter worth approximately $131,000.

Heartflow Price Performance

Heartflow stock opened at $48.91 on Tuesday. Heartflow, Inc. has a 52-week low of $20.13 and a 52-week high of $51.78. The firm's fifty day moving average is $34.05 and its 200 day moving average is $30.17. The company has a market cap of $4.25 billion and a price-to-earnings ratio of -26.73.

Heartflow (NASDAQ:HTFL - Get Free Report) last posted its earnings results on Thursday, August 13th. The company reported ($0.07) earnings per share for the quarter, topping analysts' consensus estimates of ($0.22) by $0.15. Heartflow had a negative net margin of 55.82% and a negative return on equity of 23.52%. The firm had revenue of $64.08 million for the quarter. The business's revenue was up 47.7% on a year-over-year basis. On average, equities research analysts anticipate that Heartflow, Inc. will post -0.75 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, CEO John Farquhar sold 27,230 shares of Heartflow stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $50.00, for a total value of $1,361,500.00. Following the completion of the transaction, the chief executive officer owned 360,814 shares in the company, valued at approximately $18,040,700. The trade was a 7.02% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Campbell Rogers sold 9,219 shares of the business's stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $41.23, for a total value of $380,099.37. Following the transaction, the insider directly owned 86,459 shares in the company, valued at approximately $3,564,704.57. This represents a 9.64% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 224,687 shares of company stock valued at $8,754,924 over the last ninety days. 7.70% of the stock is owned by insiders.

Analyst Ratings Changes

HTFL has been the topic of a number of recent analyst reports. JPMorgan Chase & Co. raised their target price on shares of Heartflow from $35.00 to $45.00 and gave the stock an "overweight" rating in a research note on Friday, August 14th. Benchmark reissued a "buy" rating on shares of Heartflow in a research note on Friday, August 14th. Canaccord Genuity Group raised their price objective on shares of Heartflow from $37.00 to $45.00 and gave the company a "buy" rating in a research report on Friday, August 14th. Robert W. Baird set a $45.00 target price on shares of Heartflow in a research note on Friday, August 14th. Finally, Weiss Ratings raised shares of Heartflow from a "sell (e+)" rating to a "sell (d-)" rating in a report on Friday, August 7th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $43.43.

Heartflow Company Profile

HeartFlow, Inc NASDAQ: HTFL is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company's core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow's analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow's cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.